( www.psivida.com ), headquartered in Watertown, MA, is a leader in the development of sustained release, drug delivery products for treating eye diseases. pSivida has developed three of only four FDA-approved sustained-release treatments for back-of-the-eye diseases. The most recent, ILUVIEN, a micro-insert for diabetic macular edema, licensed to Alimera Sciences, is currently sold in the U.S. and three EU countries. Retisert, an implant for posterior uveitis, is licensed to and sold by Bausch & Lomb.pSividas lead product candidate, Medidur, a micro-insert for posterior segment uveitis being independently developed, is currently in pivotal Phase 3 clinical trials, with an NDA anticipated in 2017. pSividas pre-clinical development program is focused on using its core platform technologies Durasert and Tethadur to deliver drugs and biologics to treat wet and dry age-related macular degeneration, glaucoma, osteoarthritis and other diseases. To learn more about pSivida please visit www.psivida.com and connect on Twitter, LinkedIn, Facebook and Google+. SAFE HARBOR STATEMENTS UNDER THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995: Various statements made in this release are forward-looking, and are inherently subject to risks, uncertainties and potentially inaccurate assumptions. All statements that address activities, events or developments that we intend, expect or believe may occur in the future are forward-looking statements. Some of the factors that could cause actual results to differ materially from the anticipated results or other expectations expressed, anticipated or implied in our forward-looking statements include uncertainties with respect to: Designation of Medidur as an orphan medicinal product; our ability to achieve profitable operations and access to capital; fluctuations in our operating results; further impairment of our intangible assets; declines in Retisert royalties; successful commercialization of, and receipt of revenues from, ILUVIEN for DME; the effect of pricing and reimbursement decisions on sales of ILUVIEN for DME; consequences of fluocinolone acetonide side effects; safety and efficacy results of the second Medidur Phase 3 trial, number of trials and data required for, and timing of filing and acceptance of, the Medidur NDA and EU marketing approval applications, if at all; ability to use data in a U.S. NDA from trials outside the U.S.; any exercise by Pfizer of its option with respect to the latanoprost product; our ability to develop Tethadur to successfully deliver large biologic molecules and develop products using it; our ability to successfully develop product candidates, initiate and complete clinical trials and receive regulatory approvals; our ability to market and sell products; the success of current and future license agreements; termination or breach of current license agreements; effects of competition and other developments affecting sales of products; market acceptance of products; effects of guidelines, recommendations and studies; protection of intellectual property and avoiding intellectual property infringement; retention of key personnel; product liability; industry consolidation; compliance with environmental laws; manufacturing risks; risks and costs of international business operations; legislative or regulatory changes; volatility of stock price; possible dilution; absence of dividends; and other factors described in our filings with theSEC.http://www.pfcdavidlawrence.org/usefuleyedoc/2016/09/21/these-will-enable-the-company-to-continue-to-expand-its-future-pipeline-opportunities-for-both-internal-development-as-well-as-partnerships-in-areas-outside-of-ideras-focus/
For the original version including any supplementary images or video, visit http://finance.yahoo.com/news/psivida-announces-13-patents-issued-140000846.html
Critical Elements In Glaucoma For 2015
You can even use an OTC scrub to help ease the infection. Eye pressure is measured by various methods. A chalazion looks like a sty, but mostly grows away from the edge of the eyelid. Several glands called meibomian glands modified sebaceous glands, line the margins of the eyelids. Do not use the information presented herein as a substitute for medical practitioner’s advice. Do not touch the dropper or allow it to touch your eye in order to avoid any contamination or eye infection. The foremost cause of peripheral vision problems is glaucoma. However, the main concern lies in the fact that, whether they grow back or not. In cases related to the eye, the eye drops seem to be the best treatment method. Burning red eyes is not a serious condition, and it can be easily treated by following the aforementioned treatments and through proper eye care.
As people older than 40 years are more prone to this eye disease, they should opt for regular eye check-ups to find out their intra ocular pressure. Follow the instructions given on the medicine. Other probable causes of peripheral vision loss are neurologic damage, like optic neuritis, head injuries, eye strokes, and brain damage from stroke, injury, or disease. Eyelid cysts can be a painful and annoying condition. This condition resembles a sty, however, there’s a marked difference between the two. It may not show any symptoms until the later stage of the disease. The trochlear nerve and the superior oblique muscle help us rotate our eyes and look down the stairs. This causes accumulation of glucose in the blood, which in turn leads to diabetes. The different types of ocular pain are as follows: Its most common causes is conjunctivitis or sore eye.
In China, it has been in use since 4000 years ago. The infected eye is mostly removed with the help of surgery. When this is above 21 mm Hg, it is considered to be high eye pressure and when it is below 12 mm Hg, it is called low eye pressure. http://www.oklahomasentinal.com/experteyedoc/2016/09/21/allergic-conjunctivitis-can-be-seasonal-or-perennial-year-round-depending-on-the-allergen-causing-the-reaction/However, people suffering from it are advised to be wary of being on the onset of glaucoma. Several other drugs like epinephrine, parasympathomimetics and miotics have been used to effectively to control the fluid drainage in the eye. The allergy causative can be anything one comes in contact with, thus the identification has to be done carefully, mostly by the elimination method. However, reasons that cause nerve damage or increase in the pressure are unknown. Another cause can be the presence of some foreign bodies in the eye, such as dust. There are no medicines that can elevate the levels of eye pressure.
To learn more about keyword visit http://nicekennedyharris.jcchristiancounseling.com/2016/09/21/whether-or-not-to-have-cataract-surgery-is-up-to-you-and-your-doctor/